文献
J-GLOBAL ID:202202216774198520
整理番号:22A0491082
全身性炎症反応症候群とSepsisの治療のための二重ポケットを標的とする強力で選択的なRIPK1阻害剤【JST・京大機械翻訳】
Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
著者 (24件):
Yang Xiangbo
(Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Yang Xiangbo
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Lu Huimin
(Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Lu Huimin
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Xie Hang
(Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Xie Hang
(School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China)
,
Zhang Binbin
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Zhang Binbin
(School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China)
,
Nie Tianqing
(Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Nie Tianqing
(School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China)
,
Fan Chen
(Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Yang Tao
(Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Yang Tao
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Xu Yechun
(Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Xu Yechun
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Xu Yechun
(School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China)
,
Xu Yechun
(School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China)
,
Su Haixia
(Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Su Haixia
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Tang Wei
(Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Tang Wei
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Zhou Bing
(Department of Medicinal Chemistry, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China)
,
Zhou Bing
(University of Chinese Academy of Sciences, Beijing, 10049, China)
,
Zhou Bing
(School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China)
資料名:
Angewandte Chemie. International Edition
(Angewandte Chemie. International Edition)
巻:
61
号:
5
ページ:
e202114922
発行年:
2022年
JST資料番号:
H0127B
ISSN:
1433-7851
CODEN:
ACIEAY
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)